Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs67665996 | chr17:62985827 | A/T | 8.01E-9 | 488 | 30.87 | 31.37 | 19.63 | KM Plot |
PRAD | rs677398 | chr8:104004679 | C/T | 0.000181 | 488 | 31.13 | 28.93 | 16.58 | KM Plot |
PRAD | rs67760891 | chr5:178982091 | G/A | 2.98E-11 | 486 | 30.8 | 35.8 | 15.87 | KM Plot |
PRAD | rs6780015 | chr3:105502097 | A/G | 0.000127 | 485 | 31.27 | 28.93 | 53.67 | KM Plot |
PRAD | rs6784397 | chr3:169954857 | A/C | 8.63E-5 | 486 | 26.4 | 30.77 | 31.33 | KM Plot |
PRAD | rs67935257 | chr6:169302356 | CCTT/C | 1.26E-6 | 487 | 30.87 | 31.27 | 28.78 | KM Plot |
PRAD | rs68012066 | chr7:135070852 | G/GT | 1.78E-9 | 493 | 30.8 | 31.4 | 3.03 | KM Plot |
PRAD | rs68054433 | chr5:179033961 | T/C | 1.57E-12 | 485 | 30.75 | 35.67 | 18.88 | KM Plot |
PRAD | rs6812295 | chr4:189958158 | A/G | 5.38E-5 | 494 | 38.08 | 28.57 | 31.37 | KM Plot |
PRAD | rs68126839 | chr2:178794824 | T/TTAGA | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs681859 | chr8:103998626 | C/T | 0.000155 | 494 | 16.58 | 29.23 | 31.23 | KM Plot |
PRAD | rs6851329 | chr4:72303 | A/G | 7.78E-6 | 494 | 30.53 | 32.5 | 39.23 | KM Plot |
PRAD | rs6858112 | chr4:187062426 | A/G | 1.24E-6 | 494 | 28.07 | 28.3 | 31.2 | KM Plot |
PRAD | rs6868691 | chr5:7303877 | G/A | 0.000136 | 473 | 30.87 | 32.47 | 24.85 | KM Plot |
PRAD | rs6870207 | chr5:171529721 | A/G | 6.06E-7 | 484 | 30.8 | 32 | 13.17 | KM Plot |